These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Coagulation, angiogenesis, and venous thromboembolism in cancer. Agorogiannis EI; Agorogiannis GI Lancet; 2002 Apr; 359(9315):1440. PubMed ID: 11978375 [No Abstract] [Full Text] [Related]
3. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. Fidler IJ J Natl Cancer Inst; 2001 Jul; 93(14):1040-1. PubMed ID: 11459857 [No Abstract] [Full Text] [Related]
4. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Shoji M; Hancock WW; Abe K; Micko C; Casper KA; Baine RM; Wilcox JN; Danave I; Dillehay DL; Matthews E; Contrino J; Morrissey JH; Gordon S; Edgington TS; Kudryk B; Kreutzer DL; Rickles FR Am J Pathol; 1998 Feb; 152(2):399-411. PubMed ID: 9466566 [TBL] [Abstract][Full Text] [Related]
9. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Nicosia RF Am J Pathol; 1998 Jul; 153(1):11-6. PubMed ID: 9665459 [No Abstract] [Full Text] [Related]
10. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Rosen LS Cancer Control; 2002; 9(2 Suppl):36-44. PubMed ID: 11965229 [TBL] [Abstract][Full Text] [Related]
12. Advances in the use of angiogenesis inhibitors in cancer. Pinedo HM Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080 [No Abstract] [Full Text] [Related]
13. Double target for tumor mass destruction. Saharinen P; Alitalo K J Clin Invest; 2003 May; 111(9):1277-80. PubMed ID: 12727916 [No Abstract] [Full Text] [Related]
15. [New molecular target of cancer therapy--angiogenesis regulator VEGF]. Toi M; Ueno T; Tominaga T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
17. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Dvorak HF Am J Pathol; 2003 Jun; 162(6):1747-57. PubMed ID: 12759232 [No Abstract] [Full Text] [Related]
18. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. Yin YJ; Salah Z; Maoz M; Even Ram SC; Ochayon S; Neufeld G; Katzav S; Bar-Shavit R FASEB J; 2003 Feb; 17(2):163-74. PubMed ID: 12554695 [TBL] [Abstract][Full Text] [Related]
19. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. Scola MP; Imagawa T; Boivin GP; Giannini EH; Glass DN; Hirsch R; Grom AA Arthritis Rheum; 2001 Apr; 44(4):794-801. PubMed ID: 11315918 [TBL] [Abstract][Full Text] [Related]
20. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Ferrara N; Houck K; Jakeman L; Leung DW Endocr Rev; 1992 Feb; 13(1):18-32. PubMed ID: 1372863 [No Abstract] [Full Text] [Related] [Next] [New Search]